Abbott to acquire OptiMedica and enter laser-assisted cataract surgery market
Abbott announced yesterday that it will be acquiring OptiMedica Corporation, a privately held ophthalmic device company. This will enable the leading global health care company to enter the laser-assisted cataract surgery market.
OptiMedica, a company dedicated to developing performance-driven technologies that improve patient outcomes, will be acquired for $250 million, plus additional payments totaling up to $150 million upon completion of certain milestones.
The acquisition is expected to be completed by the end of this year.
Don't miss your daily pharmaphorum news.
SUBSCRIBE free here.